Instil Bio

Instil Bio is a global, clinical-stage cell therapy company developing tumour-infiltrating lymphocytes (TIL) to treat solid tumour cancers. The company is advancing its proprietary manufacturing expertise, technology, and data into clinical trials, including a planned registrational study with its lead candidate and the first-in-human study of its next-generation engineered TIL. Their optimized TI...